Phase II Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Vascularization of Liver Metastases of Metastatic Colorectal Cancer: Proof of Concept Study
Phase of Trial: Phase II
Latest Information Update: 20 Aug 2018
Price : $35 *
At a glance
- Drugs Anakinra (Primary) ; Bevacizumab; Cisplatin; Fluorouracil; Folinic acid
- Indications Adenocarcinoma; Colorectal cancer
- Focus Proof of concept; Therapeutic Use
- Acronyms IRAFU
- 08 Aug 2018 Status changed from active, no longer recruiting to completed.
- 05 Jun 2018 Results (n=32) assessing efficacy of anakinra in combination with bevacizumab and fluorouracil, folinic acid and cisplatin (FV5FU2), were presented at the 54th Annual Meeting of the American Society of Clinical Oncology.
- 19 Jun 2017 Status changed from recruiting to active, no longer recruiting.